This TeleECHO series provides a comprehensive overview of current and emerging therapies for spondyloarthritis (SpA) conditions, translating the latest clinical data and guideline recommendations into practical, real-world applications for healthcare providers. Through case-based discussions led by experts in the field, attendees will learn to critically evaluate the benefit-risk profiles of different agents across diverse patient populations. The program is designed to enhance clinical decision-making skills, empowering participants to effectively implement strategies for treatment selection, modification, and intensification in accordance with established guidelines, ultimately resulting in improved patient outcomes. Additionally, shared decision-making will be discussed as an important component of designing treatment plans for patients with SpA conditions.